Regulatory T Cells Specific for the Same Framework 3 Region of the Vβ8.2 Chain Are Involved in the Control of Collagen II–induced Arthritis and Experimental Autoimmune Encephalomyelitis
- 19 May 1997
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 185 (10) , 1725-1733
- https://doi.org/10.1084/jem.185.10.1725
Abstract
Recent evidence indicates that chronic autoimmune disease can result from breakdown of regulation and subsequent activation of self-reactive T cells. In many murine autoimmune disease systems and in the Lewis rat, antigen-specific T cells utilizing the T cell receptor (TCR) Vβ8.2 gene segment play a major role. In the myelin basic protein–induced experimental autoimmune encephalomyelitis (EAE) model in H-2u mice, we had shown that T cells recognizing a peptide determinant within the framework 3 region of the Vβ8.2 chain have a critical role in influencing the course of the disease. Here, we report experiments in another disease system, collagen II (CII)–induced arthritis (CIA) in DBA/1LacJ (H-2q) mice, indicating a remarkably parallel control circuit to that found for EAE. A critical role is played by CII-specific Vβ8.2bearing T cells in the CIA system, which we have confirmed. Animals treated with the superantigen SEB before CII administration are significantly protected from CIA. Next, we tested the ability of peptides encompassing the entire Vβ8.2 chain to induce proliferative responses. Only TCR peptide B5 (amino acids 76–101), a regulatory peptide in EAE, induced proliferation. B5 was then used to vaccinate DBA/1LacJ mice and was shown to reduce greatly the severity and incidence of CIA as measured by joint inflammation or histology. Furthermore, similar protection was found when B5 was administered after CII immunization. It was shown that there is physiological induction of a proliferative response to B5 during CIA and that the determinant within B5 is produced from a single chain TCR construct containing the entire Vβ8.2 chain. Finally, the regulation of CIA is discussed in the context of other experimental autoimmune diseases, especially EAE, with emphasis on what appear to be strikingly common mechanisms.Keywords
This publication has 42 references indexed in Scilit:
- Natural immunodominant and experimental autoimmune encephalomyelitis-protective determinants within the lewis rat V?8.2 sequence include CDR2 and framework 3 idiotopesJournal of Neuroscience Research, 1996
- Biased t cell receptor vβ gene usage during specific stages of the development of autoimmune sialadenitis in the mrl/lpr mouse model of Sjögren's syndromeArthritis & Rheumatism, 1995
- Secretion of T cell receptor fragments from recombinant Escherichia coli cellsJournal of Molecular Biology, 1992
- Therapy against murine collagen‐induced arthritis with T cell receptor Vβ‐specific antibodiesEuropean Journal of Immunology, 1991
- Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunityCell, 1990
- The V-region disease hypothesis: evidence from autoimmune encephalomyelitisImmunology Today, 1989
- Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapyCell, 1988
- Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune interventionCell, 1988
- Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.The Journal of Experimental Medicine, 1985
- Immunisation against heterologous type II collagen induces arthritis in miceNature, 1980